|
|
 |
| FlexX docking helps in finding first low-molecular-weight inhibitors of Matriptase-2 |
|
Final ranking of a hit list from a virtual screening cascade with FlexX helped researchers in Bonn and Marburg, Germany, to design the first-ever low-molecular-weight inhibitors of Matriptase-2 — a target of high interest in novel approaches to treat cancer and iron-related maladies.
Read the orginal publication in J.Med.Chem.'s ASAP article.
|
|
|
© BioSolveIT GmbH, 2012 |
Last modified Thursday, 02. Feb 2012 23:18 CET by WebMaster |
|
